IQInvest research note
26 SEP 2026 · 00:44 ET
BMY
Bristol-Myers Squibb Company
$62.86
$1.36 (+2.21%)up 2.21%
26 September 2026 · delayed 15+ min
D-
Cut-offs are the grader's own: 97+ for an A+, below 60 is an F.
Bristol-Myers Squibb Company earns a D- on good profit margins (>10%) and strong ROE (>20%) but high debt-to-equity ratio (>2.0) and MACD bearish (negative histogram). Consider alternatives with better risk/reward profiles.
Adjusted for Moderate investors, Medium-term investors 4.0% suggested allocation Change these
IQ-BMY-20260926engine v1 · 7-category weighted scorecard